GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Envision Healthcare Corp (NYSE:EVHC) » Definitions » Altman Z-Score

Envision Healthcare (Envision Healthcare) Altman Z-Score : 0.63 (As of Apr. 27, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Envision Healthcare Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Envision Healthcare has a Altman Z-Score of 0.63, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Envision Healthcare's Altman Z-Score or its related term are showing as below:


Envision Healthcare Altman Z-Score Historical Data

The historical data trend for Envision Healthcare's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envision Healthcare Altman Z-Score Chart

Envision Healthcare Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 1.21 1.57 0.91 1.07

Envision Healthcare Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.08 1.05 1.07 1.15 0.61

Competitive Comparison of Envision Healthcare's Altman Z-Score

For the Medical Care Facilities subindustry, Envision Healthcare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envision Healthcare's Altman Z-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Envision Healthcare's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Envision Healthcare's Altman Z-Score falls into.



Envision Healthcare Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Envision Healthcare's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1134+1.4*-0.1138+3.3*-0.1466+0.6*0.7939+1.0*0.6614
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Jun. 2018:
Total Assets was $12,313 Mil.
Total Current Assets was $2,365 Mil.
Total Current Liabilities was $968 Mil.
Retained Earnings was $-1,401 Mil.
Pre-Tax Income was -1877.8 + 93.6 + -393.6 + 118.5 = $-2,059 Mil.
Interest Expense was -67.4 + -63.6 + -61.2 + -61.4 = $-254 Mil.
Revenue was 2072.8 + 2077 + 2003 + 1990.7 = $8,144 Mil.
Market Cap (Today) was $5,583 Mil.
Total Liabilities was $7,033 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2365.3 - 968.4)/12313.1
=0.1134

X2=Retained Earnings/Total Assets
=-1400.8/12313.1
=-0.1138

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-2059.3 - -253.6)/12313.1
=-0.1466

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=5582.800/7032.5
=0.7939

X5=Revenue/Total Assets
=8143.5/12313.1
=0.6614

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Envision Healthcare has a Altman Z-Score of 0.63 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Envision Healthcare  (NYSE:EVHC) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Envision Healthcare Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Envision Healthcare's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Envision Healthcare (Envision Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
AmSurg acquires and develops practice-based ambulatory surgery centers in partnership with physician groups. The company has a majority interest in 264 surgery centers in 35 states. AmSurg centers are typically single-specialty and perform procedures in the areas of gastroenterology, ophthalmology, and orthopedics.

Envision Healthcare (Envision Healthcare) Headlines

From GuruFocus

AmSurg Corp: Free Cash Flow not what it seems (AMSG)

By Frank Voisin Frank Voisin 08-04-2011

Amsurg Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2010

Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares

By GuruFocus Research GuruFocus Editor 03-17-2011

Lee Ainslie Boosts 2 Health Care Positions

By James Li James Li 02-12-2018